These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14595807)

  • 1. Protein microarrays: molecular profiling technologies for clinical specimens.
    Espina V; Mehta AI; Winters ME; Calvert V; Wulfkuhle J; Petricoin EF; Liotta LA
    Proteomics; 2003 Nov; 3(11):2091-100. PubMed ID: 14595807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein microarrays: meeting analytical challenges for clinical applications.
    Liotta LA; Espina V; Mehta AI; Calvert V; Rosenblatt K; Geho D; Munson PJ; Young L; Wulfkuhle J; Petricoin EF
    Cancer Cell; 2003 Apr; 3(4):317-25. PubMed ID: 12726858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
    Speer R; Wulfkuhle J; Espina V; Aurajo R; Edmiston KH; Liotta LA; Petricoin EF
    Cancer Genomics Proteomics; 2007; 4(3):157-64. PubMed ID: 17878519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
    Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
    Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens.
    Sanchez-Carbayo M
    Tumour Biol; 2010 Apr; 31(2):103-12. PubMed ID: 20358423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges.
    Gahoi N; Ray S; Srivastava S
    Proteomics; 2015 Jan; 15(2-3):218-31. PubMed ID: 25266292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of protein microarray technology.
    Tao SC; Chen CS; Zhu H
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):706-18. PubMed ID: 18045082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein microarrays for systems biology.
    Yang L; Guo S; Li Y; Zhou S; Tao S
    Acta Biochim Biophys Sin (Shanghai); 2011 Mar; 43(3):161-71. PubMed ID: 21257623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse phase protein arrays: mapping the path towards personalized medicine.
    Gallagher RI; Espina V
    Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein microarrays for cancer diagnostics and therapy.
    Lin JC
    Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse Phase Protein Microarrays.
    Baldelli E; Calvert V; Hodge A; VanMeter A; Petricoin EF; Pierobon M
    Methods Mol Biol; 2017; 1606():149-169. PubMed ID: 28502000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays.
    Tiemann K; Garri C; Wang J; Clarke L; Kani K
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using protein microarrays to study phosphorylation-mediated signal transduction.
    Zhang H; Pelech S
    Semin Cell Dev Biol; 2012 Oct; 23(8):872-82. PubMed ID: 22706299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse phase protein microarrays advance to use in clinical trials.
    Mueller C; Liotta LA; Espina V
    Mol Oncol; 2010 Dec; 4(6):461-81. PubMed ID: 20974554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.